Ibuprofen as Adjunct in Drug-Resistant Tuberculosis Trial
In a groundbreaking development that may redefine adjunct therapies in the battle against tuberculosis (TB), a recent phase IIA open-label ...
In a groundbreaking development that may redefine adjunct therapies in the battle against tuberculosis (TB), a recent phase IIA open-label ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine